Condition: Prostate Cancer (Adenocarcinoma)

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT07552922

Sponsor: St Vincent's Hospital, Sydney

Eligibility:

• Age: minimum 18 Years maximum N/A
• Gender: Male

Inclusion Criteria:

• Men with high-risk BCR PCa but no ADT+/-ARPI experience.
• Men with ADT+/-ARPI experience who have experienced breast-related side effects from this treatment.

Exclusion Criteria:

1. • Men receiving psychiatric care as a consequence of their prostate cancer diagnosis or treatment thereof.

View trial on ClinicalTrials.gov